BMS Halts Hep C Drug Work After Patient Dies

(MedPage Today) — Bristol-Myers Squibb announced late Thursday that it’s stopping development of an investigational drug for hepatitis C virus infection after a patient died of heart failure and eight others were hospitalized.

Post a Comment

Comments are closed.